Hyderabad, India, February 5, 2014: Mapmygenome and KIMS Foundation & Research Center (KFRC) launched Oncomap™ DNA-based test along with cancer genetic counseling services on February 4. Introduced as a World Cancer Day initiative, the event was marked by an introductory presentation and awareness drive. As part of the program, Oncomap™ and genetic counseling are being offered at discounted rates until February 10.
Oncomap™ is a simple DNA-based test that evaluates individuals’ genetic predisposition to over 15 types of cancers and common lifestyle traits. Ms. Anu Acharya, CEO of Mapmygenome, said, “The initiative aims to take Oncomap and genetic counseling closer to people, helping them in understanding the need for early screening in cancer.”
KFRC will provide genetic counseling to help people understand the role of genes in disease pathways and learn about preventive strategies. Dr. (Smt) Kanaka Bhushanam, CEO of KFRC states that genetic evaluation in cancer is the latest facility – only available at KIMS Foundation and Research Center. This is most important to fight cancer in these times of increasing worldwide prevalence of cancer.
Dr. Risha Nahar Lulla, Genetic Counselor and Scientist at KFRC, says, “Genetic counseling for cancers involves assessment of cancer genetic risk in the family members of cancer patients. Predictive genetic testing of hereditary cancers in family members must be followed by genetic counseling to understand the implications of the test report and their lifetime risk of cancer. This in turn will help to develop a customized follow up surveillance plan for early detection and treatment of cancer in these mutation-positive family members.”
Founded in August 2012, Mapmygenome is India’s pioneering Genomics Company with a vision to provide “Better Health for Indians using technology.” They offer personal genomics tests, disease detection kits, brain wellness solutions, and counseling services.
They have a range of personal genomics tests that include Genomepatri™ for personal genetic profile; Cardiomap™ genetic test for heart disease, diabetes, and other associated lifestyle conditions; and Oncomap™ test for cancer. These tests assess not only genetic risks for diseases, traits, and conditions, but also responses to several drugs prescribed for treatment. Counseling services such as genetic counseling and nutrition counseling add value to the tests. Along with their partners, Mapmygenome paves way for customers to receive the best medical attention required to mitigate the risk of diseases.
Mapmygenome also offers brain wellness solutions in India under the portfolio Mapmybrain™. This includes MyCalmBeat™ to reduce stress, to improve lung function, and to optimize heartbeat. Another innovative product in this range is WebNeuro™ test to screen cognitive strengths and efficiency.
Mapmygenome’s also offers kits for detecting and typing TB – the SMART Tuberculosis kit for RT-PCR and Spoligotyping kit for PCR. More kits will be launched soon for malaria and other diseases.
Their team at Hyderabad comprises biotechnologists, statisticians, geneticists, bioinformaticians, and genetic counsellors. Their advisory panel has expert scientists and doctors. In order to enhance this innovative brand and to provide value-added services to customers, their highly-skilled research team works on cutting-edge technologies in various domains.
For more information, visit: www.mapmygenome.in.